The associations between erythroferrone and hepcidin during iron deficiency anemia, iron overload and pregnancy
Keywords:
Erythroferrone, Pregnancy, ERFE, Hepcidin, Iron Deficiency AnemiaAbstract
Erythroferrone (ERFE) is a hormone produced by erythroblasts in the bone marrow in response to erythropoietin. Erythroferrone is a potential clinical biomarker for assessing erythropoiesis in patients with blood disorders and till now no more enough studies in erythroferrone among human, most studies are conducted in animals. Erythroferrone inhibition of hepcidin allows ferroprotein, the sole known iron exporter, to mediate the release of iron stored in gut, spleen and liver in the blood plasma. Erythroferrone functions as erythroid modulator of iron metabolism and hemoglobin synthesis. Erythroferrone is therefore a biomarker for different types of anemia, for cardiological diseases and potentially also for metabolic disease. However, few studies of the function of ERFE in humans because is recently discovered and remains to be investigated. In this review we briefly address the between erythroferrone and hepcidin during iron deficiency anemia, iron overload and pregnancy. Studies in this review were identified through a search using the following electronic databases: PubMed, Academia, Scopus, Google Scholar, and another open database source.
Downloads
References
Srole DN, Ganz T. Erythroferrone structure, function, and physiology: Iron homeostasis and beyond. J Cell Physiol. 2021 Jul;236(7):4888-4901. doi: 10.1002/jcp.30247. Epub 2020 Dec 28. PMID: 33372284; PMCID: PMC8026552.
Coffey R, Jung G, Olivera JD, Karin G, Pereira RC, Nemeth E, Ganz T. Erythroid overproduction of erythroferrone causes iron overload and developmental abnormalities in mice. Blood. 2022 Jan 20;139(3):439-451. doi: 10.1182/blood.2021014054. PMID: 34614145; PMCID: PMC8777203.
Robach P, Gammella E, Recalcati S, Girelli D, Castagna A, Roustit M, Lundby C, Lundby AK, Bouzat P, Vergès S, Séchaud G. Induction of erythroferrone in healthy humans by micro-dose recombinant erythropoietin or high-altitude exposure. Haematologica. 2020 Jan 9.
Arezes J, Foy NJ, Mchugh K, Quinkert D, Benard S, Sawant A, et al. (January 2020). "Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemia". Blood: blood.2019003140.
Nemeth E, Ganz T. The role of hepcidin in iron metabolism. Acta Haematol. 2009;122(2-3):78-86. doi: 10.1159/000243791. Epub 2009 Nov 10. PMID: 19907144; PMCID: PMC2855274.
Anderson GJ, Frazer DM. Current understanding of iron homeostasis. The American journal of clinical nutrition. 2017 Dec 1;106(suppl_6):1559S-66S.
Kautz, L., Jung, G., Valore, E. V., Rivella, S., Nemeth, E., & Ganz, T. (2014). Identification of erythroferrone as an erythroid regulator of iron metabolism. Nature genetics, 46(7), 678–684. https://doi.org/10.1038/ng.2996.
Leuenberger, N., Bulla, E., Salamin, O., Nicoli, R., Robinson, N., Baume, N. and Saugy, M., 2017. Hepcidin as a potential biomarker for blood doping. Drug testing and analysis, 9(7), pp.1093-1097.
Kumar A, Sharma E, Marley A, et alIron deficiency anaemia: pathophysiology, assessment, practical managementBMJ Open Gastroenterology 2022;9:e000759. doi: 10.1136/bmjgast-2021-000759
Yingying Yu, Li Jiang, Hao Wang, Zhe Shen, Qi Cheng, Pan Zhang, Jiaming Wang, Qian Wu, Xuexian Fang, Lingyan Duan, Shufen Wang, Kai Wang, Peng An, Tuo Shao, Raymond T. Chung, Shusen Zheng, Junxia Min, Fudi Wang; Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis. Blood 2020; 136 (6): 726–739. doi: https://doi.org/10.1182/blood.2019002907
Kautz, Léon et al. “Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia.” Blood vol. 126,17 (2015): 2031-7. doi:10.1182/blood-2015-07-658419
Kim A, Nemeth E. New insights into iron regulation and erythropoiesis. Curr Opin Hematol. 2015 May;22(3):199-205. doi: 10.1097/MOH.0000000000000132. PMID: 25710710; PMCID: PMC4509743.
Coffey, R. and Ganz, T., 2018. Erythroferrone: an erythroid regulator of hepcidin and iron metabolism. Hemasphere, 2(2).
El Gendy, F. M., EL-Hawy, M. A., Shehata, A. M. F., & Osheba, H. E. (2018). Erythroferrone and iron status parameters levels in pediatric patients with iron deficiency anemia. European Journal of Haematology, 100(4), 356–360. doi:10.1111/ejh.13021
Ginzburg, Yelena Z. “New diagnostic tools for delineating iron status.” Hematology. American Society of Hematology. Education Program vol. 2019,1 (2019): 327-336. doi:10.1182/hematology.2019000035
Cai C, Hu W, Chu T. Interplay Between Iron Overload and Osteoarthritis: Clinical Significance and Cellular Mechanisms. Frontiers in Cell and Developmental Biology. 2022:3932.
Suriapperuma T, Peiris R, Mettananda C, Premawardhena A, and Mettananda S. (2018). Body iron status of children and adolescents with transfusion dependent β-thalassaemia: trends of serum ferritin and associations of optimal body iron control. BMC research notes 11 (1), 547 BMC Res Notes. 11: 547.
Atyaf S Almousawi and Intisar Razzaq Sharba 2019 J. Phys.: Conf. Ser. 1294 062045
Papanikolaou, G., Tzilianos, M., Christakis, J. I., Bogdanos, D., Tsimirika, K., MacFarlane, J., Goldberg, Y. P., Sakellaropoulos, N., Ganz, T., & Nemeth, E. (2005). Hepcidin in iron overload disorders. Blood, 105(10), 4103–4105. https://doi.org/10.1182/blood-2004-12-4844
Camaschella, C., Nai, A. and Silvestri, L., 2020. Iron metabolism and iron disorders revisited in the hepcidin era. Haematologica, 105(2), p.260.
Talawy, Tiba Sabah, A. E. A. Altoum, and Asaad Ma Babker. "The Role of Erythroferrone Hormone as Erythroid Regulator of Hepcidin and Iron Metabolism during Thalassemia and in Iron Deficiency Anemia—A Short Review." J. Pharm. Res. Int 32 (2020): 55-59.
Delaney, K.M., 2021. Hormonal Regulation of Iron Partitioning During Pregnancy (Doctoral dissertation, Cornell University).
Babker, A.M.A.A.A. and Gameel, F.E.M.H., 2015. Molecular Characterization of Prothrombin G20210A gene Mutations In pregnant Sudanese women with spontaneous recurrent abortions. Rawal Medical Journal, 40(2), pp.207-209.
Babker, A. M. A. A. A., & Gameel, F. E. M. H. (2016). Methylenetetrahydrofolate reductase c677t polymorphism in Sudanese women with recurrent spontaneous abortions. Kuwait Medical Journal, 48(2), 100-104
Babker, A. M. (2020). The role of Inherited Blood Coagulation Disorders in Recurrent Miscarriage Syndrome. Journal of Critical Reviews, 7(1), 16-20
Delaney KM, Guillet R, Pressman EK, Ganz T, Nemeth E, O'Brien KO. Serum Erythroferrone During Pregnancy Is Related to Erythropoietin but Does Not Predict the Risk of Anemia. J Nutr. 2021 Jul 1;151(7):1824-1833. doi: 10.1093/jn/nxab093. PMID: 33982118; PMCID: PMC8245876.
Sangkhae, V., Yu, V., Coffey, R., Ganz, T. and Nemeth, E., 2021. Erythroferrone Modulates Iron Distribution for Fetal Erythropoiesis. Blood, 138, p.757.
Delaney, K., Guillet, R., Pressman, E., Nemeth, E., & O'Brien, K. (2020). Erythroferrone Is Associated with Maternal Erythropoietic Drive During Pregnancy. Current Developments in Nutrition, 4(Suppl 2), 968. https://doi.org/10.1093/cdn/nzaa054_040
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
